Send us all your questions or requests, and our expert team will assist you.
Dengue Treatment and Management
Treatment and Management of dengue fever requires a coordinated approach that balances rapid symptom relief with vigilant monitoring for complications. This page is designed for international patients, caregivers, and healthcare professionals seeking a clear understanding of how dengue is treated and managed in a world‑class setting. Each year, the World Health Organization estimates that up to 390 million people are infected, with roughly 96 million manifesting clinical symptoms—highlighting the importance of timely, evidence‑based care.
We will explore the disease’s clinical presentation, the immediate steps taken upon diagnosis, the pharmacological and supportive therapies employed, and the criteria for hospital admission. In addition, you will learn about post‑recovery follow‑up and the comprehensive services Liv Hospital provides to ensure a smooth journey from arrival to discharge.
By the end of this guide, you will have a thorough grasp of the full spectrum of dengue treatment and management strategies, empowering you to make informed decisions during a potentially serious illness.
Understanding Dengue: Symptoms and Diagnosis
Dengue infection typically begins with a sudden high fever, severe headache, pain behind the eyes, joint and muscle aches, and a characteristic rash. Early recognition is crucial because the disease can progress to severe dengue, marked by plasma leakage, hemorrhage, or organ impairment.
Diagnosis relies on a combination of clinical assessment and laboratory testing. The most common tests include:
At Liv Hospital, the laboratory team follows strict JCI‑accredited protocols to ensure rapid turnaround, often delivering results within hours. Prompt diagnosis enables clinicians to initiate appropriate treatment and management pathways before complications arise.
Test | Optimal Timing | Diagnostic Value
|
|---|---|---|
NS1 Antigen | Day 1‑5 | High sensitivity for early infection |
IgM/IgG Serology | Day 5‑7 onward | Distinguishes recent vs. past infection |
RT‑PCR | Day 1‑7 | Gold standard for viral detection |
Immediate Care and Fluid Management
One of the cornerstones of dengue treatment and management is meticulous fluid therapy. Dehydration and plasma leakage are the leading causes of severe outcomes, so clinicians focus on maintaining euvolemia while avoiding fluid overload.
Key steps include:
In severe dengue, the WHO recommends a targeted fluid replacement strategy: an initial 5–7 mL/kg over the first hour, followed by a maintenance rate of 20–30 mL/kg/day, titrated to avoid pulmonary edema. Liv Hospital’s intensive care unit is equipped with bedside ultrasound to assess fluid status in real time, ensuring precise management.
Pharmacological Options and Supportive Therapy
Currently, no antiviral medication specifically targets the dengue virus. Therefore, treatment and management rely on symptomatic relief and prevention of secondary complications.
Pharmacological measures include:
Supportive therapies extend beyond medication. Patients receive anti‑emetic care, nutritional support, and, when indicated, oxygen therapy. In cases of severe dengue with organ dysfunction, organ‑specific interventions—such as renal replacement therapy for acute kidney injury—are initiated promptly.
Monitoring Complications and Hospitalization Criteria
Identifying patients who require hospitalization is vital for preventing progression to severe dengue. The WHO outlines several warning signs that trigger admission:
Once admitted, continuous monitoring includes:
Parameter | Frequency | Critical Threshold
|
|---|---|---|
Hematocrit | Every 6 hours | Increase ≥ 20% from baseline |
Platelet Count | Every 12 hours | < 100,000 µL⁻¹; < 20,000 µL⁻¹ with bleeding |
Urine Output | Hourly | < 0.5 mL/kg/h |
Blood Pressure | Every 4 hours | Systolic < 90 mmHg |
Liv Hospital’s multidisciplinary team—including infectious disease specialists, intensivists, and nursing staff—reviews these parameters round‑the‑clock, ensuring rapid escalation of care when thresholds are crossed.
Post‑Recovery Follow‑Up and Long‑Term Management
Most patients recover fully within two weeks, but convalescent care is essential to detect lingering effects and to provide reassurance. Follow‑up visits typically occur at 1 week and 1 month post‑discharge, focusing on:
For travelers, Liv Hospital offers a personalized discharge package that includes vaccination recommendations (e.g., yellow fever, typhoid) and a detailed travel health plan. The hospital’s international patient office coordinates with local physicians abroad to ensure continuity of care.
Why Choose Liv Hospital ?
Liv Hospital combines JCI accreditation with a dedicated international patient program, offering a seamless experience from arrival to discharge. Our multidisciplinary teams bring expertise in infectious diseases, critical care, and patient navigation, ensuring that every aspect of dengue treatment and management meets the highest global standards. With state‑of‑the‑art facilities, multilingual staff, and comprehensive logistical support—including airport transfers, interpreter services, and comfortable accommodation options—international patients receive both medical excellence and personalized care.
Ready to receive world‑class dengue care? Contact Liv Hospital today to arrange your consultation, secure travel assistance, and start your recovery journey with confidence.
Send us all your questions or requests, and our expert team will assist you.
Dengue fever typically begins abruptly with a sudden high fever that can reach 40 °C (104 °F). Patients often experience a severe headache, especially behind the eyes, intense muscle and joint pains (sometimes called “break‑bone fever”), and a maculopapular rash that may appear a few days after fever onset. Other early signs can include nausea, vomiting, and mild bleeding such as gum bleeding. Recognizing these symptoms quickly is crucial because early intervention can prevent progression to severe dengue, which involves plasma leakage, hemorrhage, or organ dysfunction.
In a hospital, clinicians first evaluate the patient’s clinical presentation—fever, rash, and pain patterns—and then order specific laboratory tests. The NS1 antigen test is most sensitive within the first five days of illness and can confirm early infection. IgM and IgG serology helps differentiate recent from past infection, usually becoming positive after day five. RT‑PCR provides definitive viral identification and is considered the gold standard, especially useful for confirming dengue in the first week. Rapid turnaround, often within hours at JCI‑accredited labs like Liv Hospital’s, enables timely initiation of appropriate care.
Maintaining proper fluid balance is a cornerstone of dengue care because plasma leakage can lead to shock. For mild cases, patients receive oral rehydration solutions with balanced electrolytes. In moderate to severe dehydration, intravenous isotonic crystalloids such as Ringer’s lactate are administered. WHO guidelines recommend an initial bolus of 5–7 mL/kg over the first hour, followed by a maintenance rate of 20–30 mL/kg/day, adjusted based on hematocrit trends, urine output, and clinical signs. Liv Hospital uses bedside ultrasound to assess intravascular volume in real time, allowing precise titration and avoiding fluid overload that could cause pulmonary edema.
Since no antiviral drug targets dengue, treatment focuses on symptom relief. Acetaminophen (paracetamol) is the analgesic of choice because it reduces fever and pain without increasing bleeding risk. NSAIDs—including aspirin, ibuprofen, and other anti‑inflammatory drugs—are contraindicated as they can impair platelet function and exacerbate hemorrhagic complications. Antiemetics such as ondansetron are used for nausea and vomiting. In cases of severe thrombocytopenia with active bleeding, platelet transfusions may be considered, typically when counts fall below 20,000 µL⁻¹.
The WHO outlines specific warning signs that trigger hospitalization: persistent vomiting, severe abdominal pain, a rapid increase in hematocrit concurrent with a falling platelet count, signs of plasma leakage (e.g., pleural effusion, ascites), and any bleeding manifestations like gum bleeding or epistaxis. Once admitted, patients are monitored closely—hematocrit every 6 hours, platelet count every 12 hours, urine output hourly, and blood pressure every 4 hours. These parameters help detect early deterioration and guide escalation of care, such as fluid adjustments or organ‑supportive interventions.
After discharge, most patients recover within two weeks, but a structured follow‑up schedule helps identify any residual effects. At the first week, a complete blood count confirms normalization of hematocrit and platelet levels. At the one‑month visit, liver function tests are performed to rule out transient hepatitis. Clinicians also evaluate persistent symptoms such as fatigue, arthralgia, or mood changes. Education on mosquito avoidance and vaccination updates (e.g., yellow fever, typhoid) is provided, especially for travelers. Liv Hospital coordinates with the patient’s home‑country physicians to ensure continuity of care.
Your Comparison List (you must select at least 2 packages)
